Le rapport « Place des vaccins bivalents contre la Covid-19 Comirnaty Original/Omicron BA.1 et Comirnaty Original/Omicron BA.4-BA.5 », ci-joint, est adopté
Voir aussi
Recommandation vaccinale
20/09/2022
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
Rh9EyJY5YXzBAqAJ
